January 18, 2022
M&A
  • DaVita announced it has acquired transplant software company MedSleuth to ease access burdens on kidney and liver transplant candidates. DaVita said the acquisition will help the company support patients throughout their entire care journey, from kidney failure prevention to dialysis to transplantation, with a focus on promoting health equity. MedSleuth will operate as a subsidiary of DaVita and DaVita providers will not use MedSleuth’s products. (Press release here)
Return to Tea Leaves